CAR-T ICU 2019 | Tocilizumab for CAR-T adverse event management

Élie Azoulay

Élie Azoulay, PhD, MD, Saint-Louis University Hospital, Paris, France, explains the promising results of CAR T-cell therapy and the use of tocilizumab for the management of potential adverse events. This interview took place at the CAR-T Cell Therapy and the ICU meeting in London, UK, which was organized by EuroCARTForce.

Share this video